NAPAJEN
NapaJen Pharma is a Pharmaceutical company designed to supply drugs in effective methods to end up active form in the organ.
NAPAJEN
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2004-01-01
Address:
Burlingame, California, United States
Country:
United States
Website Url:
http://www.napajen.com
Total Employee:
1+
Status:
Active
Contact:
(650) 685-2429
Email Addresses:
[email protected]
Total Funding:
21.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics WordPress Content Delivery Network Google Universal Analytics Font Awesome Sitelinks Search Box Organization Schema JsDelivr
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Investors List
Mitsui & Co
Mitsui & Co investment in Series C - NapaJen
Innovation Network Corporation of Japan
Innovation Network Corporation of Japan investment in Series C - NapaJen
Mitsui Global Investment
Mitsui Global Investment investment in Series C - NapaJen
P&E Directions
P&E Directions investment in Series C - NapaJen
Innovation Network Corporation of Japan
Innovation Network Corporation of Japan investment in Series A - NapaJen
Official Site Inspections
http://www.napajen.com
- Host name: www3100.sakura.ne.jp
- IP address: 49.212.207.110
- Location: Osaka Japan
- Latitude: 34.6848
- Longitude: 135.5142
- Timezone: Asia/Tokyo
- Postal: 543-0062
More informations about "NapaJen"
Organization - Napajen Pharma, Inc.
Management structureSee details»
Napajen Pharma, Inc.
NapaJen Pharma is a clinical-stage, biopharmaceutical company leveraging its proprietary immune cell-targeted oligonucleotide delivery technology to develop novel therapeutics. ・Proprietary technology platform allows for efficient and …See details»
NapaJen - Crunchbase Company Profile & Funding
NapaJen Pharma is a pharmaceutical company designed to supply drugs in effective methods to end up active form in the organ. Seattle , Washington , United States 1-10See details»
Company Information | Napajen Pharma, Inc.
NapaJen Pharma, Inc. 1201 3rd Avenue, #2200, Seattle, WA 98101, USA. email: [email protected]See details»
NapaJen Pharma, Inc. - Drug pipelines, Patents, Clinical trials
NapaJen Pharma is a company that focuses on creating innovative drug delivery solutions by leveraging the body's natural cellular transport pathways. Their product line includes a lead …See details»
NapaJen Pharma, Inc. | INCJ, Ltd.
Feb 3, 2014 · Authorized Investment: USD 9 million (maximum)／USD 12 million (maximum)／USD 12 million (maximum) Announcement Date: February 3, 2014／December …See details»
NapaJen Company Profile - Office Locations, Competitors ... - Craft
NapaJen has 5 employees across 2 locations and $21.4 m in total funding,. See insights on NapaJen including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Napajen Pharma, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Napajen Pharma, Inc. of Seattle, WA. Get the latest business insights from Dun & Bradstreet.See details»
NapaJen - Contacts, Employees, Board Members, Advisors & Alumni
NapaJen has 3 current employee profiles, including Chief Scientific Officer and Co-founder Kazuaki Sakurai. NapaJen has 3 board members and advisors, including Koichi shida.See details»
NapaJen Pharma, Inc. - VentureRadar
NapaJen Pharma, Inc. VentureRadar profile. Find out more about NapaJen Pharma, Inc., DNA, RNA and Peptide Therapies.See details»
NapaJen Pharma - PitchBook
Developer of nucleic-acid drugs designed to positively impact the major challenge of side effects and toxicity in the pharmaceutical industry.See details»
NapaJen Pharma - Company Profile - Tracxn
Oct 6, 2024 · Developer of oligonucleotide therapeutics for immune diseases. The company has invented and patented a method for complexing nucleic acid oligos to Schizophyllan for …See details»
NapaJen Pharma - Overview, News & Similar companies - ZoomInfo
NapaJen Pharma. Drug Stores & Pharmacies · California, United States · <25 Employees. NapaJen Pharma, Inc. is a clinical-stage, biotherapeutics company leveraging its proprietary …See details»
Direction of the Company | Napajen Pharma, Inc.
NapaJen Pharma is a clinical-stage biopharmaceutical company developing a new level of oligonucleotide drugs that for the first time can be delivered to target immune cells, …See details»
Press Release Distribution and Management - GlobeNewswire
BURLINGAME, Calif. and TOKYO, March 18, 2019 (GLOBE NEWSWIRE) -- NapaJen Pharma, Inc., a biotherapeutics company leveraging its proprietary oligonucleotide delivery technology …See details»
NapaJen Pharma Reports Positive Results from Phase 1
Oct 8, 2020 · BURLINGAME, Calif. and TOKYO, Oct. 08, 2020 (GLOBE NEWSWIRE) -- NapaJen Pharma, Inc., a biotherapeutics company leveraging its proprietary oligonucleotide delivery …See details»
News Release - incj.co.jp
INCJ aims to establish a bio-venture industry ecosystem by providing development support for university-based drug discovery ventures and support the successful development of …See details»
NapaJen Pharma and Astellas Pharma Establish Research
Mar 18, 2019 · NapaJen will be responsible for providing Astellas with a therapeutic complex combining the novel oligonucleotide with NapaJen’s proprietary schizophyllan delivery vehicle …See details»
NapaJen Pharma Reports Positive Results from Phase 1 Clinical …
NapaJen Pharma, Inc. founded in 2004, is a clinical-stage biotherapeutics company leveraging its proprietary delivery technology to develop novel oligonucleotide drugs. NapaJen has developed aSee details»
Technology Platform | Napajen Pharma, Inc.
NapaJen’s drug delivery system (DDS) technology is the world’s first platform capable of selectively and efficiently delivering nucleic acids to target immune cells, unlocking the …See details»